Cite
Choi JS, Kim JK, Yang YJ, et al. Corrigendum to "Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells" [Pharmacol. Res. 102 (2015) 176-183]. Pharmacol Res. 2016;110:277-278doi: 10.1016/j.phrs.2016.04.017.
Choi, J. S., Kim, J. K., Yang, Y. J., Kim, Y., Kim, P., Park, S. G., Cho, E. Y., Lee, D. H., & Choi, J. W. (2016). Corrigendum to "Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells" [Pharmacol. Res. 102 (2015) 176-183]. Pharmacological research, 110277-278. https://doi.org/10.1016/j.phrs.2016.04.017
Choi, Joon-Seok, et al. "Corrigendum to "Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells" [Pharmacol. Res. 102 (2015) 176-183]." Pharmacological research vol. 110 (2016): 277-278. doi: https://doi.org/10.1016/j.phrs.2016.04.017
Choi JS, Kim JK, Yang YJ, Kim Y, Kim P, Park SG, Cho EY, Lee DH, Choi JW. Corrigendum to "Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells" [Pharmacol. Res. 102 (2015) 176-183]. Pharmacol Res. 2016 Aug;110:277-278. doi: 10.1016/j.phrs.2016.04.017. Epub 2016 Apr 29. PMID: 27137797.
Copy
Download .nbib